Showing results (631-640 of 651) with videos related to

Sort By:
Pageof 66
Biochemistry|November 27, 2013
Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Haleli Sharir, Derek M Shore, et al.
Nature Chemical Biology|February 17, 2009
Building a new conceptual framework for receptor heteromersSergi Ferré, Ruben Baler, Michel Bouvier, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2011
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activityFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Nature Communications|December 4, 2019
A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansionPeter G Boone, Lauren K Rochelle, Joshua D Ginzel, et al.
Cell|May 30, 2020
β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive BehaviorsLauren M Slosky, Yushi Bai, Krisztian Toth, et al.
British Journal of Sports Medicine|June 14, 2023
When should an athlete retire or discontinue participating in contact or collision sports following sport-related concussion? A systematic reviewMichael Makdissi, Meghan L Critchley, Robert C Cantu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacyJohn A Allen, Julianne M Yost, Vincent Setola, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neuronsMartilias S Farrell, Ying Pei, Yehong Wan, et al.
Biological Psychiatry|June 19, 2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeuticsFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Molecular Cancer Research : MCR|June 16, 2021
HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic PhaseJoshua D Ginzel, Chaitanya R Acharya, Veronica Lubkov, et al.
Pageof 66